Dr. Diamond’s research is focused on understanding the contribution of genetic variations among the genes for that encode selenium-containing to cancer risk and outcome. He has a particular focus on studying gene variations that place African Americans at great risk of dying from prostate and breast cancer.
Alan Diamond, PhD
Title & Department
Department of Department of Pathology
College of Medicine
Translational Oncology Program (TO)